Loading…
Comparing the in vitro effects of MGO™ Manuka honey and tea tree oil on ocular Demodex viability
•In vitro anti-parasitic efficacy study of 52 Demodex mites.•Mites were randomised to cyclodextrin-complexed and uncomplexed Manuka honey, tea tree oil, or no treatment application.•Mite viability was assessed for 240 min following treatment application.•Cyclodextrin-complexed Manuka honey demonstra...
Saved in:
Published in: | Contact lens & anterior eye 2018-12, Vol.41 (6), p.527-530 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c356t-856ebe15f275b614205e1711fb5d98be4ea70391e245924e8a7b504a0da95b513 |
---|---|
cites | cdi_FETCH-LOGICAL-c356t-856ebe15f275b614205e1711fb5d98be4ea70391e245924e8a7b504a0da95b513 |
container_end_page | 530 |
container_issue | 6 |
container_start_page | 527 |
container_title | Contact lens & anterior eye |
container_volume | 41 |
creator | Frame, Katie Cheung, Isabella M.Y. Wang, Michael T.M. Turnbull, Philip R. Watters, Grant A. Craig, Jennifer P. |
description | •In vitro anti-parasitic efficacy study of 52 Demodex mites.•Mites were randomised to cyclodextrin-complexed and uncomplexed Manuka honey, tea tree oil, or no treatment application.•Mite viability was assessed for 240 min following treatment application.•Cyclodextrin-complexed Manuka honey demonstrated comparable anti-demodectic efficacy to 50% tea tree oil (TTO).•Complexed honey with proven in vivo tolerability shows promise as possible alternative to TTO for demodex eradication.
To compare the in vitro antiparasitic effects of MGO™ Manuka honey and tea tree oil against ocular Demodex.
Fifty-two viable Demodex mites were acquired from the epilated eyelashes of 9 participants with blepharitis and symptomatic dry eye. Viable mites were randomised to one of five treatment groups: cyclodextrin-complexed and uncomplexed Manuka Honey, 100% and 50% tea tree oil, and no treatment. Following treatment application, mite viability was assessed for 240 min, based on limb and body movement and/or the development of a crenated/translucent appearance. Kaplan-Meier survival analysis was then performed.
The log-rank test demonstrated a significant treatment effect on the survival distribution of Demodex mites (p |
doi_str_mv | 10.1016/j.clae.2018.06.006 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2112611333</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1367048418307768</els_id><sourcerecordid>2112611333</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-856ebe15f275b614205e1711fb5d98be4ea70391e245924e8a7b504a0da95b513</originalsourceid><addsrcrecordid>eNp9kMFO3DAQhq0K1IWlL8Ch8pFLUo9jO4nUS7W0gATiAmfLTiZdL0m8tRPUvfdJ-mh9ErxaypG5zBz-_5PmI-QcWA4M1JdN3vQGc86gypnKGVMfyAmIUmVSABylu1BlxkQlFuQ0xg1LpbpmH8miYFwWdVGeELvyw9YEN_6k0xqpG-mzm4Kn2HXYTJH6jt5d3f_785femXF-MnTtR9xRM7Z0QkOngEi966kfqW_m3gR6iYNv8XfiGOt6N-3OyHFn-oifXveSPP74_rC6zm7vr25W326zppBqyiqp0CLIjpfSKhCcSYQSoLOyrSuLAk3JihqQC1lzgZUprWTCsNbU0kooluTiwN0G_2vGOOnBxQb73ozo56g5AFcARZol4YdoE3yMATu9DW4wYaeB6b1bvdF7t3rvVjOlk9tU-vzKn-2A7Vvlv8wU-HoIYPry2WHQsXE4Nti6kGTq1rv3-C-ocopN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2112611333</pqid></control><display><type>article</type><title>Comparing the in vitro effects of MGO™ Manuka honey and tea tree oil on ocular Demodex viability</title><source>ScienceDirect Journals</source><creator>Frame, Katie ; Cheung, Isabella M.Y. ; Wang, Michael T.M. ; Turnbull, Philip R. ; Watters, Grant A. ; Craig, Jennifer P.</creator><creatorcontrib>Frame, Katie ; Cheung, Isabella M.Y. ; Wang, Michael T.M. ; Turnbull, Philip R. ; Watters, Grant A. ; Craig, Jennifer P.</creatorcontrib><description>•In vitro anti-parasitic efficacy study of 52 Demodex mites.•Mites were randomised to cyclodextrin-complexed and uncomplexed Manuka honey, tea tree oil, or no treatment application.•Mite viability was assessed for 240 min following treatment application.•Cyclodextrin-complexed Manuka honey demonstrated comparable anti-demodectic efficacy to 50% tea tree oil (TTO).•Complexed honey with proven in vivo tolerability shows promise as possible alternative to TTO for demodex eradication.
To compare the in vitro antiparasitic effects of MGO™ Manuka honey and tea tree oil against ocular Demodex.
Fifty-two viable Demodex mites were acquired from the epilated eyelashes of 9 participants with blepharitis and symptomatic dry eye. Viable mites were randomised to one of five treatment groups: cyclodextrin-complexed and uncomplexed Manuka Honey, 100% and 50% tea tree oil, and no treatment. Following treatment application, mite viability was assessed for 240 min, based on limb and body movement and/or the development of a crenated/translucent appearance. Kaplan-Meier survival analysis was then performed.
The log-rank test demonstrated a significant treatment effect on the survival distribution of Demodex mites (p < 0.001). Bonferroni-corrected post-hoc pairwise analysis showed that all treatments except for uncomplexed honey effected lower survival probabilities than the untreated group (all p < 0.001). Among the four treatments, survival probabilities were lowest with 100% tea tree oil (all p < 0.001), and highest with uncomplexed honey (all p ≤ 0.001). No difference was observed between complexed honey and 50% tea tree oil (p = 0.81).
The in vitro efficacy of cyclodextrin-complexed Manuka honey was comparable with 50% tea tree oil, an established treatment for ocular Demodex. The findings support future clinical trials investigating the therapeutic effects of complexed honey in demodectic blepharitis patients.</description><identifier>ISSN: 1367-0484</identifier><identifier>EISSN: 1476-5411</identifier><identifier>DOI: 10.1016/j.clae.2018.06.006</identifier><identifier>PMID: 30253937</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Blepharitis ; Demodex ; Eyelid cleanser ; Eyelid hygiene ; Manuka honey ; Tea tree oil</subject><ispartof>Contact lens & anterior eye, 2018-12, Vol.41 (6), p.527-530</ispartof><rights>2018 British Contact Lens Association</rights><rights>Copyright © 2018 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-856ebe15f275b614205e1711fb5d98be4ea70391e245924e8a7b504a0da95b513</citedby><cites>FETCH-LOGICAL-c356t-856ebe15f275b614205e1711fb5d98be4ea70391e245924e8a7b504a0da95b513</cites><orcidid>0000-0002-9892-2964 ; 0000-0001-8297-5319</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30253937$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Frame, Katie</creatorcontrib><creatorcontrib>Cheung, Isabella M.Y.</creatorcontrib><creatorcontrib>Wang, Michael T.M.</creatorcontrib><creatorcontrib>Turnbull, Philip R.</creatorcontrib><creatorcontrib>Watters, Grant A.</creatorcontrib><creatorcontrib>Craig, Jennifer P.</creatorcontrib><title>Comparing the in vitro effects of MGO™ Manuka honey and tea tree oil on ocular Demodex viability</title><title>Contact lens & anterior eye</title><addtitle>Cont Lens Anterior Eye</addtitle><description>•In vitro anti-parasitic efficacy study of 52 Demodex mites.•Mites were randomised to cyclodextrin-complexed and uncomplexed Manuka honey, tea tree oil, or no treatment application.•Mite viability was assessed for 240 min following treatment application.•Cyclodextrin-complexed Manuka honey demonstrated comparable anti-demodectic efficacy to 50% tea tree oil (TTO).•Complexed honey with proven in vivo tolerability shows promise as possible alternative to TTO for demodex eradication.
To compare the in vitro antiparasitic effects of MGO™ Manuka honey and tea tree oil against ocular Demodex.
Fifty-two viable Demodex mites were acquired from the epilated eyelashes of 9 participants with blepharitis and symptomatic dry eye. Viable mites were randomised to one of five treatment groups: cyclodextrin-complexed and uncomplexed Manuka Honey, 100% and 50% tea tree oil, and no treatment. Following treatment application, mite viability was assessed for 240 min, based on limb and body movement and/or the development of a crenated/translucent appearance. Kaplan-Meier survival analysis was then performed.
The log-rank test demonstrated a significant treatment effect on the survival distribution of Demodex mites (p < 0.001). Bonferroni-corrected post-hoc pairwise analysis showed that all treatments except for uncomplexed honey effected lower survival probabilities than the untreated group (all p < 0.001). Among the four treatments, survival probabilities were lowest with 100% tea tree oil (all p < 0.001), and highest with uncomplexed honey (all p ≤ 0.001). No difference was observed between complexed honey and 50% tea tree oil (p = 0.81).
The in vitro efficacy of cyclodextrin-complexed Manuka honey was comparable with 50% tea tree oil, an established treatment for ocular Demodex. The findings support future clinical trials investigating the therapeutic effects of complexed honey in demodectic blepharitis patients.</description><subject>Blepharitis</subject><subject>Demodex</subject><subject>Eyelid cleanser</subject><subject>Eyelid hygiene</subject><subject>Manuka honey</subject><subject>Tea tree oil</subject><issn>1367-0484</issn><issn>1476-5411</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kMFO3DAQhq0K1IWlL8Ch8pFLUo9jO4nUS7W0gATiAmfLTiZdL0m8tRPUvfdJ-mh9ErxaypG5zBz-_5PmI-QcWA4M1JdN3vQGc86gypnKGVMfyAmIUmVSABylu1BlxkQlFuQ0xg1LpbpmH8miYFwWdVGeELvyw9YEN_6k0xqpG-mzm4Kn2HXYTJH6jt5d3f_785femXF-MnTtR9xRM7Z0QkOngEi966kfqW_m3gR6iYNv8XfiGOt6N-3OyHFn-oifXveSPP74_rC6zm7vr25W326zppBqyiqp0CLIjpfSKhCcSYQSoLOyrSuLAk3JihqQC1lzgZUprWTCsNbU0kooluTiwN0G_2vGOOnBxQb73ozo56g5AFcARZol4YdoE3yMATu9DW4wYaeB6b1bvdF7t3rvVjOlk9tU-vzKn-2A7Vvlv8wU-HoIYPry2WHQsXE4Nti6kGTq1rv3-C-ocopN</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Frame, Katie</creator><creator>Cheung, Isabella M.Y.</creator><creator>Wang, Michael T.M.</creator><creator>Turnbull, Philip R.</creator><creator>Watters, Grant A.</creator><creator>Craig, Jennifer P.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9892-2964</orcidid><orcidid>https://orcid.org/0000-0001-8297-5319</orcidid></search><sort><creationdate>201812</creationdate><title>Comparing the in vitro effects of MGO™ Manuka honey and tea tree oil on ocular Demodex viability</title><author>Frame, Katie ; Cheung, Isabella M.Y. ; Wang, Michael T.M. ; Turnbull, Philip R. ; Watters, Grant A. ; Craig, Jennifer P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-856ebe15f275b614205e1711fb5d98be4ea70391e245924e8a7b504a0da95b513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Blepharitis</topic><topic>Demodex</topic><topic>Eyelid cleanser</topic><topic>Eyelid hygiene</topic><topic>Manuka honey</topic><topic>Tea tree oil</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Frame, Katie</creatorcontrib><creatorcontrib>Cheung, Isabella M.Y.</creatorcontrib><creatorcontrib>Wang, Michael T.M.</creatorcontrib><creatorcontrib>Turnbull, Philip R.</creatorcontrib><creatorcontrib>Watters, Grant A.</creatorcontrib><creatorcontrib>Craig, Jennifer P.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Contact lens & anterior eye</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Frame, Katie</au><au>Cheung, Isabella M.Y.</au><au>Wang, Michael T.M.</au><au>Turnbull, Philip R.</au><au>Watters, Grant A.</au><au>Craig, Jennifer P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparing the in vitro effects of MGO™ Manuka honey and tea tree oil on ocular Demodex viability</atitle><jtitle>Contact lens & anterior eye</jtitle><addtitle>Cont Lens Anterior Eye</addtitle><date>2018-12</date><risdate>2018</risdate><volume>41</volume><issue>6</issue><spage>527</spage><epage>530</epage><pages>527-530</pages><issn>1367-0484</issn><eissn>1476-5411</eissn><abstract>•In vitro anti-parasitic efficacy study of 52 Demodex mites.•Mites were randomised to cyclodextrin-complexed and uncomplexed Manuka honey, tea tree oil, or no treatment application.•Mite viability was assessed for 240 min following treatment application.•Cyclodextrin-complexed Manuka honey demonstrated comparable anti-demodectic efficacy to 50% tea tree oil (TTO).•Complexed honey with proven in vivo tolerability shows promise as possible alternative to TTO for demodex eradication.
To compare the in vitro antiparasitic effects of MGO™ Manuka honey and tea tree oil against ocular Demodex.
Fifty-two viable Demodex mites were acquired from the epilated eyelashes of 9 participants with blepharitis and symptomatic dry eye. Viable mites were randomised to one of five treatment groups: cyclodextrin-complexed and uncomplexed Manuka Honey, 100% and 50% tea tree oil, and no treatment. Following treatment application, mite viability was assessed for 240 min, based on limb and body movement and/or the development of a crenated/translucent appearance. Kaplan-Meier survival analysis was then performed.
The log-rank test demonstrated a significant treatment effect on the survival distribution of Demodex mites (p < 0.001). Bonferroni-corrected post-hoc pairwise analysis showed that all treatments except for uncomplexed honey effected lower survival probabilities than the untreated group (all p < 0.001). Among the four treatments, survival probabilities were lowest with 100% tea tree oil (all p < 0.001), and highest with uncomplexed honey (all p ≤ 0.001). No difference was observed between complexed honey and 50% tea tree oil (p = 0.81).
The in vitro efficacy of cyclodextrin-complexed Manuka honey was comparable with 50% tea tree oil, an established treatment for ocular Demodex. The findings support future clinical trials investigating the therapeutic effects of complexed honey in demodectic blepharitis patients.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>30253937</pmid><doi>10.1016/j.clae.2018.06.006</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-9892-2964</orcidid><orcidid>https://orcid.org/0000-0001-8297-5319</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1367-0484 |
ispartof | Contact lens & anterior eye, 2018-12, Vol.41 (6), p.527-530 |
issn | 1367-0484 1476-5411 |
language | eng |
recordid | cdi_proquest_miscellaneous_2112611333 |
source | ScienceDirect Journals |
subjects | Blepharitis Demodex Eyelid cleanser Eyelid hygiene Manuka honey Tea tree oil |
title | Comparing the in vitro effects of MGO™ Manuka honey and tea tree oil on ocular Demodex viability |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A36%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparing%20the%20in%20vitro%20effects%20of%20MGO%E2%84%A2%20Manuka%20honey%20and%20tea%20tree%20oil%20on%20ocular%20Demodex%20viability&rft.jtitle=Contact%20lens%20&%20anterior%20eye&rft.au=Frame,%20Katie&rft.date=2018-12&rft.volume=41&rft.issue=6&rft.spage=527&rft.epage=530&rft.pages=527-530&rft.issn=1367-0484&rft.eissn=1476-5411&rft_id=info:doi/10.1016/j.clae.2018.06.006&rft_dat=%3Cproquest_cross%3E2112611333%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-856ebe15f275b614205e1711fb5d98be4ea70391e245924e8a7b504a0da95b513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2112611333&rft_id=info:pmid/30253937&rfr_iscdi=true |